Bridger Management as of Dec. 31, 2023
Portfolio Holdings for Bridger Management
Bridger Management holds 28 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Uber Technologies (UBER) | 10.6 | $27M | 445k | 61.57 | |
Godaddy Cl A (GDDY) | 9.7 | $25M | 236k | 106.16 | |
Caesars Entertainment (CZR) | 7.7 | $20M | 428k | 46.88 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 7.5 | $20M | 48k | 406.89 | |
Morgan Stanley Com New (MS) | 6.5 | $17M | 182k | 93.25 | |
Eli Lilly & Co. (LLY) | 6.3 | $16M | 28k | 582.92 | |
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 6.0 | $16M | 1.5M | 10.44 | |
Bath & Body Works In (BBWI) | 5.5 | $14M | 332k | 43.16 | |
Us Foods Hldg Corp call (USFD) | 5.5 | $14M | 312k | 45.41 | |
Endeavor Group Hldgs Cl A Com (EDR) | 4.0 | $10M | 437k | 23.73 | |
Charter Communications Inc N Cl A (CHTR) | 4.0 | $10M | 27k | 388.68 | |
Pfizer (PFE) | 3.9 | $10M | 351k | 28.79 | |
Docebo (DCBO) | 3.6 | $9.3M | 193k | 48.38 | |
Crown Holdings (CCK) | 3.5 | $9.1M | 99k | 92.09 | |
Xenon Pharmaceuticals (XENE) | 2.6 | $6.8M | 147k | 46.06 | |
Quanterix Ord (QTRX) | 1.6 | $4.2M | 155k | 27.34 | |
Springworks Therapeutics (SWTX) | 1.4 | $3.7M | 101k | 36.50 | |
ACADIA Pharmaceuticals (ACAD) | 1.4 | $3.7M | 117k | 31.31 | |
Alnylam Pharmaceuticals (ALNY) | 1.4 | $3.6M | 19k | 191.41 | |
Williams Rowland Acquisition | 1.2 | $3.1M | 297k | 10.48 | |
AtriCure (ATRC) | 1.2 | $3.1M | 87k | 35.69 | |
Catalyst Pharmaceutical Partners (CPRX) | 1.2 | $3.1M | 185k | 16.81 | |
Uniqure Nv SHS (QURE) | 0.9 | $2.5M | 362k | 6.77 | |
Alphabet Cap Stk Cl A (GOOGL) | 0.7 | $1.9M | 14k | 139.69 | |
Melco Resorts And Entmnt Adr (MLCO) | 0.7 | $1.9M | 215k | 8.87 | |
Cytokinetics Com New (CYTK) | 0.7 | $1.9M | 23k | 83.49 | |
Microsoft Corporation (MSFT) | 0.5 | $1.2M | 3.3k | 376.04 | |
Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $9.1k | 467k | 0.02 |